Metformin reduces the loss of the epithelial marker E-cadherin in TGF-β-induced MCF-7 breast cancer cells and inhibits TGF-β-induced cell dispersion and the accumulation of the mesenchymal marker vimentin in Madin-Darby canine kidney cells. Here, TGFB1 is linked to breast carcinoma.